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Background
Prime boost vaccination studies employing plasmid DNA
have been shown to significantly increase vaccine-induced
immune responses with the added advantage of increasing
vaccine-induced immune breadth. Furthermore, recent
studies have shown that prevailing immune responses to
DNA based vaccines can be substantially augmented by
the immediate application of short pulses of electric cur-
rent (electroporation) at the DNA injection site.
Methods
We vaccinated mice with DNA via the intradermal (ID),
intramuscular (IM) or combined (ID + IM) routes with
and without electroporation (EP), using a Gene Transfer
Unit (GTU®) plasmid expressing CN54gp140. Some mice
were further boosted with recombinant trimeric
CN54gp140. Female BALB/c mice (n=8) were vaccinated
every three weeks. Serum and vaginal lavage samples were
collected 1 week post each vaccination and tested by
ELISA for anti-HIV-gp140 specific IgG and IgA. Spleen
derived T cells were evaluated for antigen reactivity by
IFN-g ELISpot using 2 peptide pools of 15mers overlap-
ping by 11, spanning the full length of the gp140 molecule.
Results
Antigen-specific T lymphocyte IFN-g cytokine expression
and humoral antibody profiles were different after either
ID or IM immunization or the combined route vaccina-
tions. Moreover, we found that EP added an additional
level of complexity by influencing T and B cell responses
both quantitatively and qualitatively. As expected, these
vaccinations did not elicit biologically significant levels of
mucosal antigen-specific antibody responses.
Conclusion
Multi-route vaccinations can enhance and subtly alter vac-
cine-induced B and T lymphocyte immunity. All of the
vaccine routes benefited from enhancement to the DNA
immunization using in vivo EP and the elicited immunity
was again influenced by the enhanced transfection effi-
ciency. These strategies are likely to be useful in the future
design of vaccine modalities that seek to generate specific
immune responses.
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